Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers, today announced the introduction of its Gyrolab® HEK293 HCP Type SN Kit Reagents and Gyrolab HEK293 HCP Type CL Kit Reagents. Developed with antibodies from BioGenes GmbH, a global leader in host cell protein (HCP) assay development, the new kits enable rapid detection of HCPs from HEK293 cell lines, adding to Gyros Protein Technologies’ growing portfolio of ready-to-use host cell protein impurity kits.
Removal of HCP is a critical step in biotherapeutic development to ensure quality, consistency and stability. Importantly, HCP can trigger immune responses in patients, potentially causing adverse effects ranging from mild allergic reactions to severe immunological…